We are pleased to partner with Elicit Plant, a French agri-biotech company developing biosolutions to prevent drought stress on broad acre crops. This investment demonstrates our commitment to leveraging innovative solutions that address climate challenges in agriculture.
Detailed information can be accessed in the press release via the following link:
We are delighted to announce that we signed an agreement to acquire a majority stake in Biomapas, a leading European CRO. This partnership underscores our commitment to fostering growth and innovation in the life sciences sector.
Detailed information can be accessed in the press release via the following link:
Fight against cancer continues – we are delighted to announce our renewed investment in ITM Isotope Technologies Munich SE.
Please find the following download link to ITM´s press release.
We are pleased to announce our investment in Fotokite AG.
Fotokite is a Swiss and US-based tech company making fully autonomous tethered UAVs for firefighting and public safety teams.
You can download the press release here:
Carbyne Equity Partners invests in ITM – Isotope Technologies Munich SE together with Temasek, BlackRock, QIA, Nextech and ATHOS.
ITM is a leading radiopharmaceutical company with an advanced proprietary pipeline for cancer treatment and has established itself as the major radioisotope supplier globally. Together with Temasek, Black Rock, QIA, Nextech and Athos, this transaction is one of the largest private investment rounds in European biotech to-date. Please find the following download link to ITM´s press release: